Stay updated on Lenvatinib and Pembrolizumab in DTC Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.

Latest updates to the Lenvatinib and Pembrolizumab in DTC Clinical Trial page
- Check7 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4. This represents a minor update to the page's revision history rather than changes to the study details or user-facing content.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision tag was updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a small housekeeping update to the page's metadata rather than a change to the study details.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, signaling a minor maintenance update to the page version without altering study details.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page's Study Documents section and several blocks listing study locations, investigators, and identifiers have been removed. This reduces visibility of critical trial materials and contact information, affecting the ability to review and engage with the study record.SummaryDifference19%

- Check50 days agoChange DetectedAdded help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and header adjustments (Intervention/Treatment added; Intervention / Treatment removed) with Revision updated to v3.6.0, and the page now displays 'No longer looking for participants' to reflect closed enrollment.SummaryDifference0.4%

- Check57 days agoChange DetectedA new page revision tag Revision: v3.5.5 was added, replacing the previous tag Revision: v3.5.4. This indicates an updated version of the page content or its documentation.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib and Pembrolizumab in DTC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.